GRN and Alzheimer disease: FTD cases showed higher frontal tracer uptake than AD, and interestingly, tracer binding was higher in temporal regions in patients carrying the MAPT mutation than GRN and C9ORF72, suggesting that the different neuroinflammatory patterns may be helpful in in vivo identifying specific genetic cases [151].